Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) closed at $13.06 down -9.18% from its previous closing price of $14.38. In other words, the price has decreased by -$9.18 from its previous closing price. On the day, 0.68 million shares were traded. ARCT stock price reached its highest trading level at $14.34 during the session, while it also had its lowest trading level at $12.6.
Ratios:
For a deeper understanding of Arcturus Therapeutics Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.64 and its Current Ratio is at 5.64. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on May 28, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $32.
On January 28, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $41.
On August 12, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $70.Leerink Partners initiated its Outperform rating on August 12, 2024, with a $70 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 15 ’24 when Chivukula Pad sold 12,000 shares for $20.76 per share. The transaction valued at 249,121 led to the insider holds 435,334 shares of the business.
Chivukula Pad bought 12,000 shares of ARCT for $249,121 on Oct 15 ’24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARCT now has a Market Capitalization of 354195040 and an Enterprise Value of 179905072. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.70 while its Price-to-Book (P/B) ratio in mrq is 1.52. Its current Enterprise Value per Revenue stands at 1.252 whereas that against EBITDA is -2.288.
Stock Price History:
The Beta on a monthly basis for ARCT is 2.28, which has changed by -0.44330776 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, ARCT has reached a high of $25.88, while it has fallen to a 52-week low of $8.04. The 50-Day Moving Average of the stock is -0.57%, while the 200-Day Moving Average is calculated to be -13.59%.
Shares Statistics:
For the past three months, ARCT has traded an average of 446.22K shares per day and 359970 over the past ten days. A total of 27.12M shares are outstanding, with a floating share count of 24.83M. Insiders hold about 8.44% of the company’s shares, while institutions hold 91.89% stake in the company. Shares short for ARCT as of 1752537600 were 4481461 with a Short Ratio of 10.04, compared to 1749772800 on 4965290. Therefore, it implies a Short% of Shares Outstanding of 4481461 and a Short% of Float of 25.56.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
